Published by Coherent Market Insights
Posted on September 16, 2021
Absorbable Nasal Implant Devices Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Spirox, Inc., Intersect ENT, Inc., Mentor Worldwide LLC, Smith & Nephew, Inc., ArthroCare Corporation, Acclarent, Inc., Pfizer, Inc., and Stryker Corporation
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/5
Absorbable nasal implant devices are used to support both lower and upper lateral cartilage in the nose, strengthening the nasal wall such as polymer grafts and traditional cartilage. Such implants are used to treat nasal obstruction and allow the patient to breathe better and sleep. Nasal blockage or obstruction can be caused by several factors, such as enlarged turbinates, septal deviation, and weakened lower or/and upper lateral nasal cartilage, leading to vestibular stenosis (nasal valve collapse). Symptoms include congestion, stuffiness, or an inability to breathe through one or both nostrils.
Nasal valve collapse is a term that refers to any weakness or further narrowing of the nasal valve. Absorbable nasal implant devices improve breathing and support the nasal cartilage. These nasal implants are generally preferred for those who have undergone a rhinoplasty because of the possibility of an extremely narrow-looking nose. Absorbable nasal implant devices are important for patients where a standard treatment procedure for turbinates and septum are not enough.
Market Dynamics:
Increasing demand for nasal implant devices and the increasing adoption of advanced nasal implants by physicians is expected to propel the growth of the absorbable nasal implant devices market. For instance, in 2018, Intersect ENT announced U.S. commercial availability of the SINUVA (mometasone furoate) Sinus Implant, a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery.
Moreover, increasing adoption of better health care facilities, large patient pool, and increasing awareness about advanced nasal reconstruction procedures is expected to augment the growth of the absorbable nasal implant devices market. However, subconscious awareness about implant creating discomfort, mild pain, or irritation and stringent regulatory guidelines are expected to hamper the growth of the absorbable nasal implant market.
North America is expected to witness substantial growth of the absorbable nasal implant devices market due to increasing number of nasal obstruction cases in the region. For instance, around 3 million people in the United States visit a physician for nasal obstruction and 1 million procedures are performed to alleviate the symptoms.
In June 2019, Stryker announced that more than 33,000 nasal valve collapse (NVC) patients have been treated with its LATERA absorbable nasal implant. LATERA is used to support the lateral nasal cartilage and address the symptoms of NVC, helping patients breathe better.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/5
Reasons to Purchase this Report
• Current and future of global Absorbable Nasal Implant Devices Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Absorbable Nasal Implant Devices Market to Increase Exponentially During 2027 appeared first on Gatorledger.
Absorbable Nasal Implant Devices Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Spirox, Inc., Intersect ENT, Inc., Mentor Worldwide LLC, Smith & Nephew, Inc., ArthroCare Corporation, Acclarent, Inc., Pfizer, Inc., and Stryker Corporation
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/5
Absorbable nasal implant devices are used to support both lower and upper lateral cartilage in the nose, strengthening the nasal wall such as polymer grafts and traditional cartilage. Such implants are used to treat nasal obstruction and allow the patient to breathe better and sleep. Nasal blockage or obstruction can be caused by several factors, such as enlarged turbinates, septal deviation, and weakened lower or/and upper lateral nasal cartilage, leading to vestibular stenosis (nasal valve collapse). Symptoms include congestion, stuffiness, or an inability to breathe through one or both nostrils.
Nasal valve collapse is a term that refers to any weakness or further narrowing of the nasal valve. Absorbable nasal implant devices improve breathing and support the nasal cartilage. These nasal implants are generally preferred for those who have undergone a rhinoplasty because of the possibility of an extremely narrow-looking nose. Absorbable nasal implant devices are important for patients where a standard treatment procedure for turbinates and septum are not enough.
Market Dynamics:
Increasing demand for nasal implant devices and the increasing adoption of advanced nasal implants by physicians is expected to propel the growth of the absorbable nasal implant devices market. For instance, in 2018, Intersect ENT announced U.S. commercial availability of the SINUVA (mometasone furoate) Sinus Implant, a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery.
Moreover, increasing adoption of better health care facilities, large patient pool, and increasing awareness about advanced nasal reconstruction procedures is expected to augment the growth of the absorbable nasal implant devices market. However, subconscious awareness about implant creating discomfort, mild pain, or irritation and stringent regulatory guidelines are expected to hamper the growth of the absorbable nasal implant market.
North America is expected to witness substantial growth of the absorbable nasal implant devices market due to increasing number of nasal obstruction cases in the region. For instance, around 3 million people in the United States visit a physician for nasal obstruction and 1 million procedures are performed to alleviate the symptoms.
In June 2019, Stryker announced that more than 33,000 nasal valve collapse (NVC) patients have been treated with its LATERA absorbable nasal implant. LATERA is used to support the lateral nasal cartilage and address the symptoms of NVC, helping patients breathe better.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/5
Reasons to Purchase this Report
• Current and future of global Absorbable Nasal Implant Devices Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Absorbable Nasal Implant Devices Market to Increase Exponentially During 2027 appeared first on Gatorledger.
Explore more articles in the Research Reports category
